Srx Global logo

Srx Global(NYSEMKT) SRXH

Market Cap$27.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-99%
5 Year-100%
1 Year-93%
1 Month-14%
$1.29
-5.84%
-0.08Today
After hours$1.30+$0.01 (+0.78%)
Srx Global last closing stock price
MetricPriceDate
Last closeUSD 1.372026-10-13
Srx Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.43%USD 1.482026-10-06
1 month-13.84%USD 1.592026-09-11
3 month-39.19%USD 2.252026-07-15
Year to date-89.74%USD 13.352025-12-31
1 year-92.71%USD 18.782025-10-13
3 year-99.75%USD 540.682023-10-13
5 year-99.99%USD 10,092.642021-10-14
Since inception-98.84%USD 118.322025-04-25

Srx Global Financials at a Glance

Market Cap

$27.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-$37.41M

Net Income (TTM)

-$40.42M

EPS (TTM)

$0.00

P/E Ratio

0.01

Dividend

$0.00

Beta (Volatility)

0.71 (Low)

Price

$1.29

Volume

537,513

Open

$1.36

Previous Close

$1.29

Daily Range

$1.26 - $1.39

52-Week Range

$0.94 - $41.56

Estimated Earnings Date

Dec 25, 2026

SRXH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Srx Global

SRX Global Inc. develops artificial intelligence (AI)-powered solutions designed to improve decision-making, streamline operations, and strengthen risk management. Headquartered in Tampa, Florida, the company operates within the technology sector, specifically in the software application industry.

Products and Services
  • AI-driven decision-making tools for businesses
  • Risk management solutions tailored for various industries
  • Operational efficiency software to enhance productivity
Growth Outlook
  • Recent quarterly revenue of $3.39 million indicates stable demand
  • Strong cash position with $36.69 million in cash and equivalents
  • Market potential in AI solutions continues to expand rapidly
Financial Highlights
  • Trailing twelve months (TTM) revenue of $12.5 million shows growth potential
  • Current ratio of 27.55 suggests strong liquidity
  • Net income margin of 1.08% indicates profitability potential despite recent losses
SRX Global Inc. is positioned in a rapidly evolving market, focusing on AI solutions that cater to the growing need for enhanced decision-making and risk management. The company's recent quarterly performance reflects a consistent revenue stream, while its strong cash reserves provide a solid foundation for future growth initiatives. With the AI market expanding, SRX Global Inc. is well-placed to capitalize on emerging opportunities, making it an intriguing option for potential investors.
AI Generated • Oct 3, 2026

Industry

Food Products

Sector

Consumer Staples

Employees

21

CEO

Kent Cunningham, MBA

Website

www.srxhealth.com

Headquarters

North Palm Beach, FL 33408, US

SRXH Financials

Key Financial Metrics (TTM)

Gross Margin

32.49%

Operating Margin

-4.20%

Net Income Margin

108.05%

Return on Equity

-97.77%

Return on Capital

-233.73%

Return on Assets

-27.81%

Earnings Yield

100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$27.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

20.18M

Volume

537.51K

Avg. Volume

1.30M

Financials (TTM)

Gross Profit

-$12.16M

Operating Income

$1.57M

EBITDA

-$7.05M

Operating Cash Flow

$101.00K

Capital Expenditure

-$8.46M

Free Cash Flow

-$8.36M

Cash & ST Invst.

$49.69M

Total Debt

$0.00

Srx Global Performance Analysis

Srx Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 54,660,00018.8%
20232023-12-31USD 38,592,000-29.4%
20242024-12-31USD 34,975,000-9.4%
20252025-09-30USD 6,534,000-81.3%
Srx Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-511.0%
Q12025-12-31106.0%
Q22026-03-3122.5%
Q32026-06-30-1.4%
Srx Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -3,536.07N/A
20232023-12-31USD -1,937.34-45.2%
20242024-12-31USD -6.24-99.7%
20252025-09-30USD -127.941950.5%
Srx Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-39.2%
Q12025-12-3174.8%
Q22026-03-3191.8%
Q32026-06-3071.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$3.39M

-70.4%

Gross Profit

$904.00K

-44.2%

Gross Margin

26.65%

N/A

Market Cap

$27.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.95M

N/A

Employees

7

N/A

Net Income

-$4.14M

+72.6%

EBITDA

-$3.56M

+72.5%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$49.69M

+5348.2%

Total Debt

$0.00

-100.0%

Accounts Receivable

$8.57M

+5.2%

Inventory

$2.61M

-49.1%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-27.81%

N/A

Return on Invested Capital

1.10%

N/A

Free Cash Flow

-$956.00K

+94.1%

Operating Cash Flow

-$956.00K

+94.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SNSESensei Biotherapeutics, Inc.
$13.85-22.28%
MRKRMarker Therapeutics, Inc.
$0.89-3.75%
CLRBCellectar Biosciences, Inc.
$1.18-15.11%
BOLTBolt Biotherapeutics, Inc.
$3.98-7.12%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$221.30-3.16%
BACBank of America
$51.39-4.76%
CRWVCoreWeave
$65.78-15.46%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%

Questions About SRXH

What is the current price of Srx Global?

Srx Global is trading at $1.29 per share.

What is the 52-week range for Srx Global?

Over the past 52 weeks, Srx Global has traded between $0.94 and $41.56.

How much debt does Srx Global have?

As of the most recent reporting period, Srx Global reported total debt of $0.00.

How much cash does Srx Global have on hand?

Srx Global reported $36.69M in cash and cash equivalents in its most recent financial results.

What is Srx Global’s dividend yield?

Srx Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services